Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: A cross sectional study in Kinondoni Municipality

BMC Pharmacology and Toxicology

Volumn 15, Issue 1, 2014, Pages

  Manyanga, Vicent P ^a   Minzi, Omary ^a   Ngasala, Billy ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Anaemia; Co trimoxazole prophylaxis; HIV; Malaria; Pregnancy

Indexed keywords

COTRIMOXAZOLE; HEMOGLOBIN; ANTIINFECTIVE AGENT;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FIRST TRIMESTER PREGNANCY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA; PATIENT COMPLIANCE; PREGNANT WOMAN; PREVALENCE; RISK FACTOR; SECOND TRIMESTER PREGNANCY; TANZANIA; THIRD TRIMESTER PREGNANCY; YOUNG ADULT; ANTIBIOTIC PROPHYLAXIS; CD4 LYMPHOCYTE COUNT; IMMUNOLOGY; PREGNANCY;

ADULT; ANEMIA; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; MALARIA; PREGNANCY; PREVALENCE; TANZANIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84906928242     PISSN: None     EISSN: 20506511     Source Type: Journal    
DOI: 10.1186/2050-6511-15-24     Document Type: Article

References (35)

1. Steketee R, Wirima J, Bloland P, Chilima B, Mermin J: Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with Human Immunodeficiency Virus type-1. Am J Trop Med Hyg 1996, 55(1):42-49.
2. Ter Kuile FO, Parise ME, VerhoeffFH, Udhayakumar V, Newman RD, Van Eijk AM, Rogerson SJ, Steketee RW: The burden of co-infection with Human Immunodeficiency Virus type 1 and malaria in pregnant women in Sub-Saharan Africa. Am J Trop Med Hyg 2004, 71(2):41-54.
3. Mount AM, Mwapasa V, Elliott SR, Beeson JG: Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004, 363(9424):1860-1867.
4. Ned RM, Moore JM, Chaisavaneeykorn S, Udhayakumar V: Modulation of immune responses during HIV-malaria co-infection in pregnancy. Trends Parasitol 2005, 21(6):284-291.
5. World Health Organization: Guideline on co-trimoxazole prophylaxis for HIVrelated infections among children, adolescents and adults in resource-limited settings. Recommendations for a public health approach. Geneva; 2006.
6. Ministry of Health and Social Welfare: Tanzania National Guideline for Prevention of Mother-to-child Transmission of HIV/AIDS. Dar Es Salaam; 2011.
7. De Castro MC, Yamagata Y, Mtasiwa D, Tanner M, Utzinger J, Keiser J, Singer BH: Integrated urban malaria control: a case study in Dar Es Salaam. Am J Trop Med Hyg 2004, 71(Suppl 2):103-117.
8. Omo-Aghoja LO, Abe E, Feyi-Waboso P, Okonofua FE: The challenges of diagnosis and treatment of malaria in pregnancy in low resource settings. Acta Obstet Gynecol 2008, 87(7):693-696.
9. Uneke CJ: Diagnosis of Plasmoduim falciparum malaria in pregnancy in Sub-Saharan Africa: the challenges and public health implications. J Parasitol Res 2008, 102:333-342.
10. Leke RFG, Djokam RR, Mbu R, Leke RJ, Fogako J, Megnekou R, Matenou S, Sama G, Zhou Y, Cadigan T, Parra M, Taylor DW: Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria. J Clin Microbiol 1999, 37(9):2992-2996.
11. The Municipal Medical Officer of Health: Kinondoni municipality profile. Dar Es Salaam; 2008.
12. Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, Achan J, Havlir D, Rosenthal PJ, Dorsey G, Clark TD, Cohan D: Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J 2009, 8:254.
13. Morisky D, Green L, Levine D: Concurrent and predictive validity of a selfreported measure of medication adherence. J Med Care 1986, 24(1):67-74.
14. Morisky DE, Ang A, Krousel-wood M: Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertesion 2009, 10(5):348-354.
15. World Health Organization: Prevention and management of severe anaemia in pregnancy. Geneva; 1993.
16. World Health Organization: WHO, case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva; 2007.
17. Kapito-tembo A, Hensbroek van B, Phiri K, Fitzgerald M, Meshnick SR, Mwapasa V: Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with Or without Sulfadoxine-Pyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis 2011, 203:464-472.
18. World Health Organization: Malaria rapid diagnostic tests: Test of Performance. Geneva; 2008.
19. World Health Organization: A strategic framework for malaria prevention and control during pregnancy in the African region. Geneva; 2004.
20. Renggli S, Mandike R, Kramer K, Patrick F, Brown NJ, McElroy PD, Rimisho W, Msengwa A, Mnzava A, Nathan R, Ntunge R, Mgullo R, Lweikiza J, Lengeler C: Design, implementation and evaluation of a national campaign to deliver 18 million free long-lasting insecticidal nets to uncovered sleeping spaces in Tanzania. Malar J 2013, 12:1.
21. Maxwell CA, Msuya E, Sudi M, Njunwa KJ, Carneiro IA, Curtis CF: Effect of community-wide use of insecticide-treated nets for 3-4 years on malarial morbidity in Tanzania. J Trop Med Int Heal 2002, 7(12):1003-1008.
22. West PA, ProtopopoffN, Rowland M, Cumming E, Rand A, Drakeley C, Wright A, Kivaju Z, Kirby MJ, Mosha FW, Kisinza W, Kleinschmidt I: Malaria risk factors in North West Tanzania: the effect of spraying, nets and wealth. PLoS One 2013, 8(6):e65787.
23. Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P: Effect of co-trimoxazole prophylaxis, antiretroviral therapy and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006, 367:1256-1261.
24. Tanzania National AIDS Control Program: National Guideline for the Management of HIV/AIDS. Dar Es Salaam; 2012.
25. Finkelstein JL, Mehta S, Duggan CP, Spiegelman D, Aboud S, Kupka R, Msamanga GI, Fawzi WW: Predictors of anaemia and iron deficiency in HIV-infected pregnant women in Tanzania: a potential role for vitamin D and parasitic infections. Public Health Nutr 2013, 15(5):928-937.
26. Mehta S, Manji KP, Young AM, Brown ER, Chasela C, Taha E, Read JS, Golnberg RL, Fawzi WW: Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr 2008, 87(6):1639-1649.
27. Uneke CJ, Duhlinska DD, Igbinedion EB: Immunodeficiency Virus infection and anaemia during pregnancy in eastern Nigeria: The public health implication. Infect Dis Clin Pract 2007, 15(4):239-244.
28. Nkhoma ET, Kalilani-phiri L, Mwapasa V, Rogerson SJ, Meshnick SR: Effect of HIV infection and Plasmodium falciparum parasitemia on pregnancy outcomes in Malawi. Am J Trop Med Hyg 2012, 87(1):29-34.
29. Walker AS, Mulenga V, Ford D, Kabamba D, Sinyinza F, Kankasa C, Chintu C, Gibb DM: The impact of daily co-trimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clin Infect Dis 2007, 44:1361-1367.
30. Weiss G, Goodnough LT: Anaemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
31. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW, Sullivan BPS: Epidemiology of anaemia in Human Immunodeficiency Virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998, 91:301-308.
32. Ziske J, Kunz A, Sewangi J, Lau I, Dugange F, Hauser A, Kirschner, Harms G, Theuring S: Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child transmission of HIV in Tanzania. PLoS One 2013, 8(2):e55633.
33. World Health Organization: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach. Geneva; 2010.
34. Sharma SK: Zidovudine-induced anaemia in HIV/AIDS. Indian J Med Res 2010, 132:359-361.
35. Sinha G, Choi TJ, Nayak U, Gupta A, Nair S, Gupte N, Bulakh PM, Satry J, Deshmukh SD, Khandekar MM, Kulkarni V, Bhosele RA, Bharuche KE, Phadke MA, Kshirsagar AS, Bolinger RC: Clinically significant anaemia in HIVinfected pregnant women in India is not a major barrier to Zidovudine use for prevention of maternal-to-child transmission. J Acquir Immune Defic Syndr 2007, 45:210-217.